There is currently no cure for Parkinson’s, but early and accurate diagnosis is crucial to give patients access to the range of treatment and therapies available.  Early intervention can slow the progression of the disease and dramatically improve quality of life.

Diagnosing Parkinson’s is currently a challenge. Early symptoms are attributable to a range of causes and by the time they become more pronounced the disease is often well advanced.  Conclusive diagnosis can require expensive DaTscan brain-imaging equipment and the expertise of specialists.

The DiPAR sensor pen has the potential to revolutionise diagnosis. It will be able to distinguish between Parkinson’s and other motor-neurological impairments, and detect early indicators of the disease. The technology will be relatively inexpensive and will not require specialist expertise to administer.

With these advantages, it will become much easier to diagnose Parkinson’s in time for patients to benefit from the treatments and therapies available.